ABSTRACT-It has been reported that amiodarone induces disorders of alveolar macrophages and pul monary fibrosis, but the mechanism is not well-understood. This study was performed to elucidate the toxic mechanism from the standpoint of cellular function. Using alveolar macrophages obtained from a male Slc:ICR mouse, several injuries caused by amiodarone were compared to those caused by amantadine and mianserin as cationic amphiphilic drugs (CADs). As parameters for the drug effects, H+-ATPase and acid sphingomylinase activities, cellular pH, cytokine and prostaglandin releases, phagocytosis and neutral red uptake were measured. Amiodarone decreased H+-ATPase activity initially and subsequently increased cellular pH and decreased acid sphingomyelinase activity. These changes, which were also observed with amantadine and mianserin, were considered to be CAD-related. Amiodarone increased cytokine and prostaglandin releases and suppressed neutral red uptake and phagocytosis. These changes, being not induced by amantadine and mianserin, were considered to be specific for amiodarone. The above data suggest that amiodarone has two types of toxic effects on alveolar macrophages.
Amiodarone hydrochloride, an iodinated benzofuran derivative, is a class-III antiarryhythmic drug that is effective for resistant ventricular and superventricular arrhythmias (1) . However, the use of amiodarone is restricted because of a variety of adverse reactions, i.e., hypothyroidism, dermatologic damage, hepatic toxicity, neurologic toxicity, ophthalmologic injury, cardiovascu lar toxicity, and the most serious of all, pulmonary toxic ity (2-4). The precise mechanism by which pulmonary toxicity develops in patients treated with amiodarone is not well-known, although it has been suggested that alterations in pulmonary phospholipid metabolism are causally related to the amiodarone-induced toxicity (5) .
Amiodarone belongs to a family of cationic am phiphilic drugs (CADs), i.e., the drugs consisting of a basic amine group attached via a short side chain to a hydrophobic moiety; this group of drugs include amanta dine, imipramine, mianserin, tripelennamine and more than 30 other compounds (6) . Although these drugs vary widely in their principal pharmacological actions, CADs have been shown to cause lipidosis in humans, animals and cultured cells (7). Hostetler and Matsuzawa found that several CADs inhibited the activities of lysosomal phospholipases A and C, enzymes that are active toward most of the phosphoglycerides (8). In addition, high doses of these CADs damage cell membranes and cellular function as well as reduce cell viability (6) . A previous study presented the toxicity of amiodarone using mouse alveolar macrophages, which play a role in the early stages of inflammation and in controlling infection by releasing cytokines (9). However, the previous study did not confirm the specific toxicity of amiodarone toward the alveolar macrophages nor define the precise mecha nism for the release of cytokines from alveolar macro phages treated with amiodarone. Therefore, this study was carried out to investigate the specificity of disorders caused by amiodarone in alveolar macrophages, in com parison with the disorders caused by other CADs such as amantadine and mianserin that are known to have no pulmonary toxicity, but suppress acid sphingomyelinase activites and induce lysosomal inclusion bodies in fibro blasts and cell lines (10, 11).
Myelinoid body formation in cells treated with CADs was suggested to be related to changes in several lyso somal enzymes, e.g., acid sphingomyelinase (12), acid phospholipase (13) and H+-ATPase activities, and to cause a change in cellular pH (14), but the details of the mechanisms are yet to be elucidated in detail. Therefore, the activities of the lysosomal enzymes were measured to define the mechanism of CADs-induced disorders. Addi tionally, because the previous results did not confirm cel lular function disorders of the macrophages treated with amiodarone, except for its cytokine releasing effect (9), the following functional parameters were determined:
phagocytosis by a macrophage-specific functional test (15), neutral red uptake as a lysosomal functional test (16), the release of cytokine and prostaglandin as media tors of inflammation (17), and protein kinase C (PKC) activity and sphingosine concentration as factors in the signal transduction pathway (18). In addition, in order to find the triggering point of amiodarone-induced disorders in alveolar macrophages, time-dependent changes caused by amiodarone were measured.
MATERIALS AND METHODS

Materials
Hydrochloride compounds of amiodarone, mianserin and amantadine were purchased from Sigma Chemical Co., Ltd. (St. Louis, MO, USA). Recombinant mouse interleukin-1~ (IL-1p) and recombinant mouse tumor necrosis factor a (TNFa) and their respective polyclonal antibodies (generated in rabbits), i.e., anti mouse IL-1~ antibody and anti mouse TNFa antibody, were purchased from Genzyme Co., Ltd. (Cambridge, UK). The other reagents used in this study were special grade. Amioda rone, mianserin and amantadine were dissolved in 5010 ethyl alcohol and then diluted with phosphate-buffered saline (PBS, pH 7.4).
Isolation and cultivation of mouse alveolar macrophages Alveolar macrophages were isolated by the adhesion method (9). In brief, male S1c:ICR mice (8-weeks-old, SPF) were purchased from Japan SLC Co., Ltd.
(Shizuoka). These animals were anesthetized by intra peritoneal injection with sodium pentobarbital at a dose of 25 mg/kg, and after exsanguination, the trachea of each mouse was exposed. After a tracheal catheter was attached, warm minimum essential (MEM) medium (Dainippon Pharmaceutical Co., Ltd., Osaka) was intro duced into the trachea until the lung was expanded to
give an almost 80° increase in lung volume. Thereafter, the medium contained in the lungs was aspirated to recover the cells suspended in the medium. This proce dure was repeated 10 times, and the recovered media were pooled. After the pooled medium was centrifuged at 1000 x g for 5 min at 15'C, the pellet was collected and suspended in the culture medium, i.e., MEM medium supplemented with 10% fetal bovine serum (Dainippon Pharmaceutical Co., Ltd.). These cells were then washed two times with the culture medium, added to plastic dish es (PrimariaTM, FalconTM; Nippon Becton Dickinson Co., Ltd., Tokyo) previously coated with 10°10 fetal bovine serum, and incubated for 1 hr at 371C in an atmosphere of 5% CO2 and 95% air. After each dish was washed with the medium to remove non-adherent cells, the same type of medium, but supplemented with 0.5% ethylenediaminetetraacetic acid (Wako Pure Chemical, Inc., Osaka), was added to the dish to release the adher ent cells, i.e., the alveolar macrophages. These cells were washed three times with the medium, and the final cell suspension was adjusted to a concentration of 8 x 104 cells/ml. Cells expressing acid phosphatase, a macro phage phenotypic marker, were identified by staining for this enzyme. In preliminary tests, 95% of the 200 cells counted were acid-phosphatase-positive.
Experimental procedures First, we examined the toxicity of amiodarone in com parison with those of mianserin and amantadine. The final concentrations of each drug were 0.01, 0.1, 1 and 10 jM, and the duration of drug treatment was 24 hr. Next, a time-dependent examination was performed to define the mechanism of the toxicities caused by amiodarone at a concentration of 10,uM. The duration of drug treat ment was 10, 30, 60, 90 and 120 min and 4, 6, 12 and 24 hr. Concentrations used in these experiments were based on the previous report (9) and on dosages used in rats (19) . Ethyl alcohol (0.1 ° v/v) was used as the control for drug treatment. The medium from the treated cell cul tures, the viable cells and cell homogenates of these treat ed cells prepared in PBS were the materials for several examinations. Five dishes were used for each experiment.
Determination of cytotoxicity, and cytokines and pro staglandins in the culture medium of the alveolar macro phages treated with drugs After inoculation of 1 ml of alveolar macrophage sus pension (8 x 104 cells) into each well of a 24-well plastic culture plate (FalconTM), the plate was incubated for 2 days at 37C under an atmosphere of 5 % CO2 and 9510 air. Thereafter, amiodarone, mianserin or amantadine solution was added to a given well, and the plate was then incubated for 24 hr under the above culture conditions. The number of viable cells was counted microscopically after trypsinization and staining with trypan blue (Wako Pure Chemical Inc.) solution. Then, the medium was col lected, and its supernatant was obtained by centrifugation (3000 x g for 5 min at 41C). Cytokine concentrations in these supernatants of culture medium were determined by the TR-FIA method (Pharmacia Biotech Co., Ltd., Uppsala, Sweden) using a DELFIA fluorometer (Model 1232) (20) . Prostaglandin (PG) E2 and PGF2a in the super natants of culture medium from alveolar macrophages treated with drugs were determined with an ELISA kit (Cayman Chemical Co., Ltd., Ann Arbor, MI, USA).
Concentrations of cytokines and PGs in the medium were expressed as picograms per 104 cells.
Determination of H+-ATPase, acid sphingomyelinase, acid phospholipase A2 and PKC activities of alveolar macrophages Proton/potassium-ATPase (H+-ATPase) activity in the homogenates of cells treated with drug for 24 hr at 37C was determined by the fluorometric method of Sabolic et al. (21) using FITC-dextran (Sigma Chemical Co., Ltd.) and a fluorometer (F-4010; Hitachi, Tokyo). The homogenates of the cells treated with the desired drug(s) were prepared according to the previously described method (9): after cells were washed with PBS two times and trypsinized with 0.25016 trypsin solution, the collected cells were washed two times with PBS, and the cell num ber was counted and adjusted to 1 x 105 cells per 1 ml of PBS. Then, the cell suspension was sonicated for 10 min at 4 C with a sonicator (Labsonic, B.B. Brown Co., Ltd., Bonn, Germany), and these sonicated homogenates were used for determinations of the parameters described be low. Acid sphingomyelinase activity was determined by the method described by Jaffrezou et al. (10). Briefly, a fluorescent pyrenesulfonylamidoundecanoyl sphingomye lin substrate (Sigma Chemical Co., Ltd.) was added to the desired sonicated homogenates of cells that was treated with drug(s) for 24 hr at 37C, and the samples were then incubated in the presence of Triton X-100 (Wako Pure Chemical Inc.) for 2 hr at 37C. The reaction was stopped by adding 1.5 ml heptane and 0.45 ml isopropyl alcohol followed by 0.25 ml water and centrifugation at 1000 x g for 10 min at room temperature. The product of the en zyme reaction was determined fluorometrically, with ex citation and emission wavelengths set at 351 and 378 nm, respectively. One unit of acid sphingomyelinase activity was defined as 1 nmol of ceramide produced per hr. Acid phospholipase A2 activity in homogenates of cells treated with the desired drug(s) for 24 hr at 371C was determined as described previously with pyrene-labeled lecithin as a substrate by the method of Hendrickson and Rauk (22) . One unit of this enzyme activity was defined as 1 nmol of substrate destroyed per min. PKC activity was measured with an NRPKTM (Non-radioisotopic protein kinase) kit (MBL Co., Ltd., Nagoya) modified for TR-FIA using the DELFIATM system (9). One unit of PKC activity was defined as the amount of enzyme producing 1 pmol of phosphorylated peptide per min. These enzyme activities were expressed as units per 104 cells obtained after drug treatment.
Determination of sphingosine concentrations in alveolar macrophages Sphingosine concentrations in homogenates of alveolar macrophages treated with the desired drug were deter mined fluorometrically (23) 
Determination
of phagocytosis, uptake of neutral red, and differential cellular pH Fluorescein isothiocyanate (FITC)-labeled sheep erythrocytes (Dainippon Pharmaceutical Co., Ltd.) were added to the alveolar macrophages treated with the desired drug and incubated at 37V for 2 hr in an atmos phere of 5% CO2 and 95% air. After incubation, the cells were washed three times with culture medium, suspended in distilled water, homogenized and centrifuged at 1000 x g for 10 min at room temperature. Phagocytic activity expressed by the intensity of FITC in the resulting supernatant was determined at 520-nm emission wavelength (24) . The uptake of neutral red into the cells was determined by the previously described method (16), briefly summarized as follows: 0.5 ml of 0.05 mg/ml neu tral red solution was added to the cells, and incubation was carried out for 3 hr at 37C. After extraction with Formalin-calcium solution, a solution of acetic acid and ethyl alcohol was added to the extract, and the absorb ance was determined at 540 nm with a microplate reader (Spectramax 280, Wako Pure Chemical, Inc.). Changes in differential cellular pH were determined fluorometri cally with acridine orange according to the previously described method (25) . After the drug-treated cells were stained with 201tM acridine orange for 1 hr at 37C, they were washed with PBS, and their fluorescent intensities were determined at an excitation wavelength of 435 nm and emission wavelengths of 510 and 624 nm with a fluorometer. Differential pH was calculated according to the standard curve prepared previously. The data were expressed as absorbance per 104 cells after drug treat ment.
Statistical analyses
Results were expressed as the mean and standard de viation (S.D.) of five dishes. The magnitude of these decreases was less than that with amiodarone. macrophages treated with amiodarone at 0.1 teM or higher had significant concentration-dependent decreases in acid sphingomyelinase activity. Cellular pH in the cells treated with mianserin and amantadine only was increased at the highest tested concentration of each. Mianserin and amantadine decreased H+-ATPase and acid sphingomyelinase activities only at the highest con centration of 10 eM. The magnitude of changes in these enzyme activities of cells treated with amiodarone was larger than that obtained with mianserin or amantadine. In addition, acid phospholipase A2 activities in the macro phages treated with amiodarone, mianserin and aman tadine were also decreased in a concentration-dependent manner (data not shown). Table 2 indicates medium concentrations of IL-13 and PGE2, PKC activity and sphingosine concentration in the macrophages, phagocytosis of the cells, and neutral red uptake into the cells. Amiodarone at 0.1 pM or higher increased the IL-1p release in a concentration-dependent manner. Concentrations of PGE2 in the medium also in creased after amiodarone treatment at concentrations of 1 pM or higher. The concentrations of cytokine and PG in the medium of mianserin or amantadine-treated cul tures, however, were the same as those of vehicle-treated ones. Also, TNFa and PGF2a concentrations released from the macrophages treated with amiodarone only were increased in a concentration-dependent manner (data not shown). PKC activities and sphingosine concentration in the macrophages were increased and decreased, respec tively, in a concentration-dependent manner, when the cells were treated with amiodarone at 0.1 pM or higher. However, mianserin and amantadine affected neither the PKC activity nor the sphingosine concentration in the macrophages. Only amiodarone at concentrations of 1 and 10 pM decreased phagocytosis and neutral red up take, whereas mianserin and amantadine at the highest dose had no effect on these functions regardless of the decrease in viable cell number. Table 2 . Effects of amiodarone, mianserin and amantadine on medium concentrations of IL-lp and PGE2, sphingosine concen tration, PKC activity, phagocytosis and neutral red uptake in mouse alveolar macrophages Mouse alveolar macrophages were treated with amiodarone, mianserin or amantadine at 371C for 24 hr under a 5% CO2 and 95° air atmosphere. Data are expressed as the mean±S.D. (n=5) and analyzed by Dunnett's test. Significant difference from the control: **P<0.01.
Time-dependent changes caused by amiodarone Table 3 shows H+-ATPase and acid sphingomyelinase activities and cellular pH changes from 10 min to 12 hr after exposure to amiodarone. The earliest change was a decrease in H+-ATPase activity, which occurred at 30 min after the start of drug treatment.
Next, an increase in cellular pH was observed at 60 min after the start of treatment, and a decrease in acid sphingomyelinase activ ity was found at 90 min and later after the addition of the drug. The above three parameters had in common the feature that the values reached by 2 hr remained constant for longer than 10 hr.
Changes with time for the other parameters examined in this study were indicated as a percentage of the control from 1 hr to 24 hr, as seen in Fig. 2 . A decrease in the sphingosine concentration in the cells began at 2 hr after the start of amiodarone treatment. An increase in PKC activity was also shown from 2 hr and proceeded in a time-dependent manner. From 6 hr to 24 hr of drug treatment, cytokine concentrations in the medium were increased. Especially, increases in PG concentrations were remarkably stimulated at 24 hr. Finally, phagocyto sis and neutral red uptake were dramatically impaired only at 24 hr after the start of treatment. Also, a decrease in viable cell number was found only at 24 hr (data not shown).
DISCUSSION
When the toxicity induced by amiodarone was com pared to those by amantadine and mianserin, we observed that the changes in cellular pH, and in H+-ATPase, acid sphingomyelinase and acid phospholipase A2 activities were caused by all three tested drugs, mianserin, amanta dine and amiodarone, indicating that it is likely that these four parameters are affected by the toxicity of CADs in general. In addition to the injuries induced by CADs, amiodarone showed specific functional and physiological toxicities: it reduced phagocytic activity and neutral red uptake and increased the release of inflammatory cytokines and PGs. Accordingly, these results indicate that amiodarone has two types of toxicities toward alveo lar macrophages, CAD-related and amiodarone-specific ones. Furthermore, this study indicated that the amio darone-specific cellular functional damages and CAD related injuries in mouse alveolar macrophages might in duce complicated pulmonary toxicities. In fact, this sug gestion was supported by the previous observations that patients or animals administered amiodarone suffered from complex damages such as hyperlipidosis (14), im munological disorders (26) , inflammatory injuries (27) and bronchoalveolar cellularity changes (28) . Additionally, the time-dependency studies indicated that the decrease in H+-ATPase activity is apparently an initial effect, occurring the most rapidly at 30 min after the addition of amiodarone. H+-ATPase activity ap peared to be the parameter most sensitive to the drug be cause only it was affected at the lowest concentration (0.01 uM) of amiodarone tested. These findings suggested that the decrease in H+-ATPase activity might be the trigger point of amiodarone-induced disorders in alveolar macrophages. Next, an increase in cellular pH was ob served, at 60 min after drug addition; and subsequently, a decrease in acid sphingomyelinase activity was found at 90 min. Because changes in cellular pH and H+-ATPase and acid sphingomyelinase activities were commonly in duced by CAD-class drugs, it would appear that amioda rone impaired incipiently CAD-sensitive factors. With regard to amiodarone-specific toxicity, a drop in sphin gosine concentration in the cells appeared first, and then an increase in PKC activity was found. Because sphingo sine is a product from sphingolipid and ceramide via sphingomyelinase action and because sphingosine inhibits PKC activities (18), the observed decrease in sphin gomyelinase activity might induce the decrease in produc tion of sphingosine which might in turn lead to stimula tion of PKC activity. Already, it is known that amioda rone stimulates PKC activity in mouse alveolar macro phages (9), considering that PKC induces the production and release of several cytokines and that several cytokines induce the production and release of PGs (18). With respect to the relationship between these functional dis orders and cell death, the results that mianserin and amantadine had no effect on the above functions at the doses causing cell death indicate that the functional dis orders caused by amiodarone is specific to amiodarone.
In conclusion, this study demonstrated that amioda rone has two different types of toxicities toward mouse alveolar macrophages in vitro: one is CAD-related and the other is amiodarone-specific. However, because it is known that desethylamiodarone, a major metabolite of amiodarone, induces pulmonary toxicity in animals like amiodarone does (29) and the serum concentration of desethylamiodarone reaches about 60°7o of those of amiodarone (30) , it would be of interest to perform additional studies with desethylamiodarone to examine in more detail the mechanisms underlying amiodarone induced disorders.
